Vesicare

   
Google
 
Web NewDrugInformation.com

Vesicare


Drug - Vesicare
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Solifenacin Succinate
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Solifenacin Succinate. May repeat for multiple part products.

Applicant - ASTELLAS
The firm name holding legal responsibility for Vesicare. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021518
The FDA assigned number to Vesicare. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Vesicare. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 19, 2004
The date Vesicare was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Vesicare. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Vesicare is in. Format is RX, OTC, DISCN.

Applicant Full Name - Astellas Pharma Us Inc
The full name of the firm holding legal responsibility for the new application of Vesicare.

Vesicare